Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial

医学 雄激素剥夺疗法 前列腺癌 临床终点 危险系数 放射治疗 前列腺特异性抗原 内科学 前列腺 肿瘤科 外照射放疗 泌尿科 外科 随机对照试验 置信区间 癌症
作者
Liselotte M.S. Boevé,Maarten C.C.M. Hulshof,André N. Vis,Aeilko H. Zwinderman,Jos W. R. Twisk,Wim P.J. Witjes,K.P.J. Delaere,R. Jeroen A. van Moorselaar,Paul C.M.S. Verhagen,George van Andel
出处
期刊:European Urology [Elsevier BV]
卷期号:75 (3): 410-418 被引量:495
标识
DOI:10.1016/j.eururo.2018.09.008
摘要

The cornerstone of standard treatment for patients with primary bone metastatic prostate cancer (mPCa) is androgen deprivation therapy (ADT). Retrospective studies suggest a survival benefit for treatment of the primary prostatic tumour in mPCa, but to date, no randomised-controlled-trials (RCTs) have been published addressing this issue. To determine whether overall survival is prolonged by adding local treatment of the primary prostatic tumour with external beam radiation therapy (EBRT) to ADT. The HORRAD trial is a multicentre RCT recruiting 432 patients with prostate-specific antigen (PSA) >20 ng/ml and primary bone mPCa on bone scan between 2004 and 2014. Patients were randomised to either ADT with EBRT (radiotherapy group) or ADT alone (control group). Primary endpoint was overall survival. Secondary endpoint was time to PSA progression. Crude and adjusted analyses were applied to evaluate treatment effect. Median PSA level was 142 ng/ml and 67% of patients had more than five osseous metastases. Median follow up was 47 mo. Median overall survival was 45 mo (95% confidence interval [CI], 40.4–49.6) in the radiotherapy group and 43 mo (95% CI: 32.6–53.4) in the control group (p = 0.4). No significant difference was found in overall survival (hazard ratio [HR]: 0.90; 95% CI: 0.70–1.14; p = 0.4). Median time to PSA progression in the radiotherapy group was 15 mo (95% CI: 11.8–18.2), compared with 12 mo (95% CI: 10.6–13.4) in the control group. The crude HR (0.78; 95% CI: 0.63–0.97) was statistically significant (p = 0.02). The current RCT comparing ADT to ADT with EBRT to the prostate in patients with primary bone mPCa did not show a significant difference in overall survival, although the CI cannot exclude a substantial survival benefit. Further research is needed to confirm our findings. This study investigated the effect of adding radiation therapy to the prostate to hormonal therapy in prostate cancer patients with metastasis to the bone at diagnosis. In our patient group, additional radiotherapy did not improve overall survival. Further research is needed to confirm our findings. Adding radiotherapy to the prostate in patients with bone metastatic prostate cancer does not improve overall survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
manzhi发布了新的文献求助10
刚刚
英吉利25发布了新的文献求助10
刚刚
Hina完成签到,获得积分10
刚刚
double_x完成签到,获得积分10
1秒前
beiest发布了新的文献求助10
3秒前
3秒前
Llllllxxxxxxx发布了新的文献求助10
3秒前
VAD123发布了新的文献求助30
3秒前
Hello应助难过的谷芹采纳,获得10
3秒前
dypdyp应助leeom采纳,获得10
3秒前
3秒前
4秒前
Aquila关注了科研通微信公众号
5秒前
汪汪汪完成签到,获得积分10
5秒前
张钰欣关注了科研通微信公众号
5秒前
ljxx发布了新的文献求助10
6秒前
Ava应助王博林采纳,获得10
6秒前
狂野的河马完成签到,获得积分10
6秒前
6秒前
6秒前
7秒前
前进四19发布了新的文献求助30
7秒前
7秒前
勤奋的松鼠完成签到,获得积分10
7秒前
Ava应助WFLLL采纳,获得10
7秒前
7秒前
迷人乐荷完成签到,获得积分10
8秒前
背后的鹭洋完成签到,获得积分10
8秒前
美丽梦秋完成签到,获得积分10
8秒前
luyjabc发布了新的文献求助10
8秒前
派大星和海绵宝宝完成签到,获得积分10
9秒前
淡淡的发卡完成签到,获得积分10
9秒前
今后应助makus采纳,获得10
9秒前
白潇潇完成签到,获得积分10
9秒前
9秒前
zym完成签到 ,获得积分10
10秒前
暗黑同学完成签到,获得积分10
10秒前
Mrande完成签到,获得积分10
11秒前
越战越勇完成签到,获得积分10
11秒前
潘潘发布了新的文献求助10
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969094
求助须知:如何正确求助?哪些是违规求助? 3514055
关于积分的说明 11171564
捐赠科研通 3249344
什么是DOI,文献DOI怎么找? 1794799
邀请新用户注册赠送积分活动 875377
科研通“疑难数据库(出版商)”最低求助积分说明 804779